The Adalimumab Biosimiliar Pipeline: What's AheadByStephanie Pilat, PharmD,Viktoriya Avlasevich, PharmD,Lisa Cristofaro, PharmD, BS, BCACPJuly 21st 2023FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.